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PERSPECTIVE

Neurotrophic factors: promising
candidates in tissue regeneration
Neurotrophic factors, also referred as neurotrophins, are
growth factors originally identified in the nervous system.
As indicated by the name, neurotrophic factors are essential
for the survival and development of neurons. Nerve growth
factor (NGF) is the first identified neurotrophic factor, and
is necessary for the development of sensory neurons in the
dorsal root ganglia, and cholinergic neurons (Levi-Montalcini and Hamburger, 1951). Brain derived neurotrophic
factor (BDNF) is required for survival of sensory neuron in
the dorsal root ganglia, hippocampus and cerebral cortex,
but not for motor neurons (Conover et al., 1995). On the
other hand, Neurotrophin-3 (NT-3) is critical for the survival and proliferation of both sensory neurons, and motor
neurons (Woolley et al., 2005). Glial cell derived neurotrophic factors (GDNF) family of ligands (GFLs) include
GDNF, neurturin (NRTN), artemin (ARTN) and persephin
(PSPN). GFLs enhance the survival of dopaminergic neurons in the midbrain (Lin et al., 1993), as well as the survival of enteric neurons in the gastrointestinal tract (Sanchez
et al., 1996). Neuropoietic cytokines, such as ciliary neurotrophic factor (CNTF) and leukemia inhibitory factor (LIF)
are also considered members of neurotrophic factor family,
and promote survival of multiple types of neurons and glial
cells (Stolp, 2013).
There are numerous reports on the role of neurotrophic
factors in healthy and damaged neurons. Neurotrophic
factors promote the development, survival, proliferation,
and differentiation of healthy neurons. They also exhibit a
role in anti-inflammation, anti-apoptosis, re-myelination
and axon regeneration, thereby facilitating neuronal tissue
regeneration.
More recent discoveries indicate that neurotrophic factors
are expressed in non-neuronal tissues, and may play a role
in the tissue repair as well. NGF, BDNF, and NT3 have been
noted to promote proliferation, vascularization, and neural
differentiation in mesenchymal cells such as bone marrow
stem cells (BMSCs) and fibroblasts. NT3 and GDNF are reported to promote ovarian follicle differentiation (Nilsson
et al., 2009) and spermatogenesis respectively (Meng et al.,
2000). GDNF is also critical in the ureteric bud origina-
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tion during kidney development (Sanchez et al., 1996). In
addition, increased level of NGF is linked with improved
regeneration of cardiomyocytes (Caporali et al., 2008) and
pancreatic islet (Hata et al., 2015)(Figure 1).
In a recent study, we reported that GDNF is enriched in
the salivary gland stem cells (SSCs), but not in the acinar
cell. More interestingly, the expression of GDNF in the SSCs
is elevated post radiation to the head and neck region in
both mice and humans. This neurotrophic factor is able
to increase the proliferation of SSCs in a dose dependent
manner in vitro. We also found that one time delivery of
GDNF to the salivary gland either before or post radiation
to the head and neck region of the mice would significantly
increase the number of surviving SSCs, improve the morphology of the salivary gland and rescue the saliva secretion. The data suggested that GDNF protects the salivary
gland from radiation induced damage by promoting salivary gland stem cell regeneration and proliferation in vivo
(Xiao et al., 2014).
Besides the healthy tissues, neurotrophic factors are also
reported to regulate tumor cell growth, invasion, metastasis
along nerve, and resistance to therapy. BDNF is found to enhance the proliferation of malignant gliomas, breast cancer
and lung cancer. GDNF pathways have been associated with
growth and metastasis of neuroblastoma, glioma, breast cancer, small cell lung cancer, thyroid cancer, pancreatic cancer,
colon cancer and testicular cancer. It would be necessary to
test whether GDNF promotes head and cancer (HNC) survival, proliferation and migration, before applying it to the
post radiation HNC patients.
The mechanism through which neurotrophic factors mediate tissue regeneration and tumor cell behaviorstill needs
further investigation. NGF, BDNF and NTs (Neurotrophins)
bind to the neurotrophin receptor p75 at low affinity. The
binding between NGF, BDNF, NTs and the receptor tyrosine
kinases (Trk) are stronger and more specific. NGF specifically binds to TrkA while BDNF preferentially binds to TrkB.
NT-3 preferentially binds to TrkC, but can also activate TrkA
and TrkB, while NT-4/5 preferentially binds to TrkB. The
PI3K/AKT, MEK/ERK are reported to be downstream of the
neurotrophin activation (Skaper, 2012). GDNF is the most
well studied member of the GFL family. It preferentially
binds to the receptor GFRα1, which then activates the receptor tyrosine kinase RET or the neural cell adhesion molecule (NCAM) (Zhou et al., 2003). The PI3K/AKT, MEK/
ERK, SRC/c-Jun kinase (JNK), FYN/focal adhesion kinase
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Figure 1 Schematic map of neurotrophic factors and
their functions.
The neurotrophic factors include multiple members,
which play various roles in neuronal and non-neuronal tissue regeneration. ARTN: Artemin; BDNF: brain
derived neurotrophic factor; GDNF: glial cell derived
neurotrophic factor; NGF: nerve growth factor; PSPN:
persephin.
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(FAK) pathways have all been reported to be downstream
of the GDNF signal. In our study, elevated GDNF were
found co-localized with NCAM and phosphorylated FAK
signal in the SSC of post radiation HNC patients. Although
phosphorylated AKT and phosphorylated ERK level both
increased in the post radiation salivary gland, the signal was
neither enriched in SSCs nor overlay with GDNF. The results
indicate that GDNF mainly work through the NCAM and
FAK pathway in promoting salivary gland regeneration (Xiao
et al., 2014).
These results indicate that neurotrophic factors could
be promising drug candidates for tissue regeneration in
the future. Neurotrophic factors and their modulators are
tested in clinical trials already for treating neurodegenerative diseases, such as Alzheimer’s disease (NCT01163825,
NCT00876863, NCT02271750) and Parkinson’s disease
(NCT00985517, NCT01621581), progressive supranuclear palsy (NCT00005903), traumatic brain injury
(NCT01212679, NCT02276079), and cerebral radiation necrosis (NCT02032147). Neurotrophic factors are delivered
to patients through direct injection, infusion pumps, encapsulated particles, virus mediated infection, etc. A clinical
study on the safety and efficacy of a recombinant human
NGF eye drop solution is ongoing recruiting patients with
persistent epithelial defect of cornea or keratitis of the cornea (NCT01756456, NCT01411657). Neuropoietic cytokine
CNTF has been shown in several clinical models to enhance
survival and regeneration of the retinal ganglion neurons
(NCT01408472). There are controversies about applying
the neurotrophic factors. Amgen withheld the clinical trial
of GDNF on patients with Parkinson’s in 2004 concerning
the efficacy and safety issues. With the increasing evidences
indicating the drug delivery method may play critical role
in the effect, MedGenesis Therapeutix Inc. reopened the
trial using convection enhanced delivery method to deliver
GDNF.
It is promising to see more bedside studies on the potential therapeutic effect of neurotrophic factors, as more
and more benchside studies demonstrate that neurotrophic
factors play important roles in regulating stem cell behavior
and promotes tissue regeneration.
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